Evotec SE

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

52.21%

Market Cap

618.47 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.58 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE3.454 G0 Units
PRICE DETERMINATION TIME07/16/2026 / 09:55:52 PM
DAILY VOLUME (UNITS)20,540
DAILY HIGH / LOW3.5363.392
PREV. DAY'S PRICE3.482 (07/15)
CHANGE DAY BEFORE
-0.03
-0.80 %
52 WEEK HIGH / LOW7.8 (07/30)3.284 (07/14)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.47-1.11-0.58-0.52-0.16
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
3.361.531.19--
PRICE - SALES RATIO
4.821.821.23--
PRICE - CASH FLOW RATIO
110.8980.96---
Further Key Figures

Master Data

WKN
566480
ISIN
DE0005664809
SYMBOL
EVT
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Evotec
INDEX MEMBERSHIP
TecDAX, SDAX
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
177.62 Mil.
MARKET CAPITALISATION
618.47 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
Performance
-28.27 %
-28.18 %
-36.86 %
-45.01 %
-52.21 %
-84.00 %
-90.55 %
-36.34 %
High5.095.235.786.617.8024.4045.626.69
Low3.283.283.283.283.283.283.283.28

Dividende

pro Aktie
Evotec does not deliver dividend information

Company profile

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

(in 28 days)
08/13/26Q2 2026 Earnings Call
(in 28 days)
08/13/26Q2 2026 Earnings Release
(in 47 days)
09/01/26Antibody CMC Development Xchange Meeting
(in 54 days)
09/08/26Nordic Life Science Day
(in 68 days)
09/22/26BioProcess International US East Conference